Tripedia

Tripedia®

Pediatrics A trivalent vaccine–diphtheria and tetanus toxoids, acellular pertussis

Tripedia

(trī-pēd′ē-ă)
Diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed. Dtap vaccine.
References in periodicals archive ?
Formulation Adjuvant Adverse reactions Tripedia Aluminum potassium sulfate 11,178 Daptacel Aluminum phosphate 8,786 Infanrix Aluminum hydroxide 13,238 TABLE 7: Adverse reactions reported in VAERS for sulfate versus hydroxide in age-matched samples, and the likelihood that the contrasts observed in these distributions could have occurred by chance (p < 0.05).
Selected Vaccines That Contain Gelatin Indication Vaccine diptheria, tetanus, and acellular pertussis (DTaP) Tripedia DTaP/Haemophilus influenzae type B combination TriHIBit influenza Fluzone Jaapanese encephalitis JE-Vax measles, mumps, and rubella (MMR) MMR-II measles, mums, rubella, and varicella (MMRV) ProQuad typhoid (oral form) Vivotif varicella Varivax yellow fever YF-Vax zoster Zostavax Source: The Pink Book 11th ed.
Various other vaccines also contain gelatin, such as Tripedia (diphtheria, tetanus, and acellular pertussis), Fluzone (influenza), Zostavax (zoster), and Varivax (varicella), said Dr.
In TriHIBit[R], Haemophilus influenzae type b (Hib) vaccine ActHIB[R] is reconstituted with the Tripedia DTaP vaccine.
With the March 2001 approval of a second diphtheria and tetanus toxoid and pertussis vaccine (DTaP) that does not contain thimerosal as a preservative (Aventis Pasteur's Tripedia, trace thimerosal), all DTaP vaccines currently being produced in the U.S.
production of Tripedia. Other manufacturers are also developing new vaccines.
Jackson of the University of Washington, Seattle, and her colleagues conducted a randomized, blinded controlled trial within a larger safety study of the Tripedia DTaP vaccine.
Tripedia or Infanrix for doses 1-4, Acel-Imune for all 5 doses), but whole DTP is an acceptable alternative if no DTaP is available.
Tripedia, the acellular pertussis (DTaP) vaccine was approved by the FDA for the primary series in infants on July 31, 1996.
Three vaccines are now licensed in the United States: SKB-3P (Infanrix), CB-2 (Tripedia), and CLL-4[F.sub.2] (DAPTACEL).
The first DTaP vaccine on the US market to get approval for five dose was Tripedia, manufactured by Aventis Pasteur.